Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin

被引:38
作者
Tsiang, M [1 ]
Jain, AK [1 ]
Gibbs, CS [1 ]
机构
[1] GILEAD SCI INC,FOSTER CITY,CA 94404
关键词
D O I
10.1074/jbc.272.18.12024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutation of 79 highly exposed amino acids that comprise approximately 62% of the solvent accessible surface of thrombin identified residues that modulate the inhibition of thrombin by antithrombin III, the principal physiological inhibitor of thrombin, Mutations that decreased the susceptibility of thrombin to inhibition by antithrombin III in the presence and absence of heparin (W50A, E229A, and R233A) also decreased hydrolysis of a small tripeptidyl substrate, These residues were clustered around the active site cleft of thrombin and were predicted to interact directly with the ''substrate loop'' of antithrombin III, Despite the large size of antithrombin III (58 kDa), no residues outside of the active cleft were identified that interact directly with antithrombin III, Mutations that decreased the susceptibility of thrombin to inhibition by antithrombin III in the presence but not in the absence of heparin (R89A/R93A/E94A, R98A, R245A, K248A, K252A/D255A/Q256A) in general did not also affect hydrolysis of the tripeptidyl substrate, These residues were clustered among a patch of basic residues on a surface of thrombin perpendicular to the face containing the active site cleft and were predicted to interact directly with heparin, Three mutations (E25A, R178A/R180A/D183A, and E202A) caused a slight enhancement of inhibition by antithrombin III.
引用
收藏
页码:12024 / 12029
页数:6
相关论文
共 41 条
[1]   SPATIAL STRUCTURE OF THROMBIN AS A GUIDE TO ITS MULTIPLE SITES OF INTERACTION [J].
BODE, W ;
STUBBS, MT .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1993, 19 (04) :321-333
[2]  
BODE W, 1992, PROTEIN SCI, V1, P426
[3]   ROLE OF THE THROMBIN INSERTION LOOP-144-155 - STUDY OF THROMBIN MUTATIONS W148G, K154E AND A THROMBIN-BASED SYNTHETIC PEPTIDE [J].
BOUTON, MC ;
PLANTIER, JL ;
DEMBAK, M ;
GUILLIN, MC ;
RABIET, MJ ;
JANDROTPERRUS, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (02) :526-532
[4]   DECIPHERING THE MESSAGE IN PROTEIN SEQUENCES - TOLERANCE TO AMINO-ACID SUBSTITUTIONS [J].
BOWIE, JU ;
REIDHAAROLSON, JF ;
LIM, WA ;
SAUER, RT .
SCIENCE, 1990, 247 (4948) :1306-1310
[5]  
BROZE GJ, 1994, MOL BASIS BLOOD DISE, P629
[6]  
CHURCH FC, 1989, J BIOL CHEM, V264, P18419
[7]   AN ALLOSTERIC SWITCH CONTROLS THE PROCOAGULANT AND ANTICOAGULANT ACTIVITIES OF THROMBIN [J].
DANG, QD ;
VINDIGNI, A ;
DICERA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :5977-5981
[8]   Rational engineering of activity and specificity in a serine protease [J].
Dang, QD ;
Guinto, ER ;
DiCera, E .
NATURE BIOTECHNOLOGY, 1997, 15 (02) :146-149
[9]   THE NA+ BINDING-SITE OF THROMBIN [J].
DICERA, E ;
GUINTO, ER ;
VINDIGNI, A ;
DANG, QD ;
AYALA, YM ;
WUYI, M ;
TULINSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22089-22092
[10]   THE REGULATION OF NATURAL ANTICOAGULANT PATHWAYS [J].
ESMON, CT .
SCIENCE, 1987, 235 (4794) :1348-1352